NSEAnalysts/Institutional Investor Meet/Con. Call Updates5d ago · 2 Nov 2026, 06:10 pm

Analysts/Institutional Investor Meet/Con. Call Updates

Caplin Point Laboratories Limited · CAPLIPOINT

✦ AI SummaryResults

Caplin Point Laboratories Limited has informed the Exchange about a post-results conference call with analysts, fund houses, and investors to discuss the financial performance for the quarter and half year ended September 30, 2026.

Analysis Scores

Earnings Impact8/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact9/10
Market Sentiment6/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Caplin Point Laboratories Limited has informed the Exchange about Schedule of meet

Attachments (1)

📄

CAPLINPOINT_02112026181011_Analyst_Meet_SE_intimation_Q2_sd.pdf

pdf

Download →
View document text
November 02, 2026 BSE Limited National Stock Exchange of India Ltd Department of Corporate Relationship Department of Corporate Services 1st Floor, New Trade Ring, Rotunda Building Exchange Plaza, 5th Floor, Phiroze Jeejeebhoy Towers C-1, Block G,Bandra Kurla Complex, Dalal Street, Mumbai- 400001 Bandra (E),Mumbai – 400 051 Scrip Code: 524742 S c r i p C o d e : C A P L I P O I N T . Dear Sir / Madam, Sub : Compliance under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 In terms of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby intimate that a post-results conference call with the analyst’s / fund houses/ investors will be held on Thursday, November 12, 2026, at 4:30 PM. (IST) to discuss the financial performance of the Company for the quarter and half year ended September 30, 2026. A copy of the Conference Call Invitation is enclosed for your reference. Kindly take the same on your records. The schedule of the aforesaid meeting is subject to change due to exigencies on the part of Analyst / Company. Sincerely Yours For Caplin Point Laboratories Limited Venkatram G General Counsel & Company Secretary Membership No. A23989 Encl: A/a Caplin Point Laboratories Limited invites you to the Q2 and H1 FY2027 Earnings Conference Call on Thursday, November 12th, 2026 at 16:30 hours IST Caplin Point Laboratories Limited, a rapidly expanding and fully integrated pharmaceutical company, following its Q2 and H1 FY2027 results announcement, invites you to the earnings conference call on Thursday, 12th November 2026 at 16:30 hours IST to discuss the financial results and business outlook. The management team will be represented by: • Mr. C.C. Paarthipan – Chairman • Mr. Vivek Partheeban – Vice Chairman • Mr. Ashok Partheeban – Vice Chairman • Dr. Sridhar Ganesan – Managing Director • Mr. D. Muralidharan – Whole Time Director and CFO Earnings Conference Call on Thursday, 12th November 2026 at 16:30 hours IST Diamond Pass: Click Here to Register for the Event +91 22 6280 1222 Universal Dial-In: +91 22 7115 8123 Hong Kong: 800 964 448 Singapore: 800 101 2045 International Toll-Free USA: 1 866 746 2133 UK: 0 808 101 1573 Please register in advance for this earnings conference call using the above link to ensure that you are connected on time. For any queries, please contact: Churchgate Partners 360 One CM Research Soham Arora / Simran Malhotra Mr. Rohit Bhat / Mrs. Julie Mehta +91 73032 11037 +91 22 4031 7150 caplinpoint@churchgatepartners.com julie.mehta@360.one